Last reviewed · How we verify
The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye
This study aims to evaluate the efficacy and safety of 3% Diquafosol Ophthalmic Solution for visual display terminal (VDT)-associated dry eye and to investigate the mechanism of treatment.
Details
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | PHASE4 |
| Status | UNKNOWN |
| Enrolment | 68 |
| Start date | Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Mar 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Dry Eye Syndromes
- Computer Vision Syndrome
- Asthenopia
Interventions
- Diquafosol
Countries
China